Keryx Biopharmaceuticals

Keryx Biopharmaceuticals

Biopharmaceutical company focused on the development and commercialization of innovative medicines.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR20152017
R&D budget30.0m27.0m

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
*
N/A

$110m

Post IPO Equity

N/A

Acquisition
Total Funding-

Recent News about Keryx Biopharmaceuticals

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.